Ulf dé Fairé

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

Björn Dahlöf, Richard B. Devereux, Sverre E. Kjeldsen et al. · The Lancet · 2002 · 5.4K citations

Medicine, Cardiology, Internal Medicine +13

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

Lennart Hansson, Lars Lindholm, Leo Niskanen et al. · The Lancet · 1999 · 2K citations

Medicine, Cardiology, Pharmacology +16

Large-scale association analysis identifies new risk loci for coronary artery disease

Panos Deloukas, Stavroula Kanoni, Christina Willenborg et al. · Nature Genetics · 2012 · 1.7K citations · Full text

Medicine, Biostatistics, Cardiology +14

Genetic Variants Associated with Lp(a) Lipoprotein Level and Coronary Disease

Robert Clarke, John F. Peden, Jemma C. Hopewell et al. · New England Journal of Medicine · 2009 · 1.6K citations · Full text

Medicine, Genetics, Molecular Genetics +17

Air pollution and lung cancer incidence in 17 European cohorts: prospective analyses from the European Study of Cohorts for Air Pollution Effects (ESCAPE)

Ole Raaschou‐Nielsen, Zorana Jovanovic Andersen, Rob Beelen et al. · The Lancet Oncology · 2013 · 1.6K citations · Full text

Medicine, Environmental Sciences, Health Sciences +17